MedTrace Logo

Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles

NCT05767086 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 297

Last updated 2024-10-15

No results posted yet for this study

Summary

The aim of study is to evaluate the results of three different protocols for prevention of premature ovulation in ovarian stimulation cycles. All patients that undergo IVF cycles are randomly divided into three groups. The first group is cetrorelix, the second group is medroxyprogesterone acetate and the third group is dydrogesterone.

Conditions

Interventions

DRUG

Gonadotropin releasing hormone antagonist (Cetrotide)

clinical pregnancy rates

DRUG

Medroxyprogesterone Acetate (Tarlusal)

clinical pregnancy rates

DRUG

Dydrogesterone

clinical pregnancy rates

Sponsors & Collaborators

  • Bezmialem Vakif University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05767086 on ClinicalTrials.gov